How to buy OncoCyte Corporation Common Stock stock

OncoCyte Corporation Common Stock is a biotechnology business based in the US. OncoCyte Corporation Common Stock shares (OCX) are listed on the NASDAQ and all prices are listed in US Dollars. OncoCyte Corporation Common Stock employs 51 staff and has a trailing 12-month revenue of around 0.00.

OncoCyte Corporation Common Stock share price

Use our graph to track the performance of OCX stocks over time.

OncoCyte Corporation Common Stock shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$1.15 - $6.57
50-day moving average	$4.80
200-day moving average	$3.46
Wall St. target price	$7.71
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.37

Buy OncoCyte Corporation Common Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy OncoCyte Corporation Common Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of OncoCyte Corporation Common Stock by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OncoCyte Corporation Common Stock financials

Revenue TTM	$1.2 million
Gross profit TTM	$-639,000
Return on assets TTM	-41.06%
Return on equity TTM	-93.07%
Profit margin	0%
Book value	$0.48
Market capitalisation	$393.9 million

TTM: trailing 12 months

Shorting OncoCyte Corporation Common Stock shares

There are currently 2.3 million OncoCyte Corporation Common Stock shares held short by investors – that's known as OncoCyte Corporation Common Stock's "short interest". This figure is 8.9% up from 2.1 million last month.

There are a few different ways that this level of interest in shorting OncoCyte Corporation Common Stock shares can be evaluated.

OncoCyte Corporation Common Stock's "short interest ratio" (SIR)

OncoCyte Corporation Common Stock's "short interest ratio" (SIR) is the quantity of OncoCyte Corporation Common Stock shares currently shorted divided by the average quantity of OncoCyte Corporation Common Stock shares traded daily (recently around 1.3 million). OncoCyte Corporation Common Stock's SIR currently stands at 1.77. In other words for every 100,000 OncoCyte Corporation Common Stock shares traded daily on the market, roughly 1770 shares are currently held short.

However OncoCyte Corporation Common Stock's short interest can also be evaluated against the total number of OncoCyte Corporation Common Stock shares, or, against the total number of tradable OncoCyte Corporation Common Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OncoCyte Corporation Common Stock's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 OncoCyte Corporation Common Stock shares in existence, roughly 30 shares are currently held short) or 0.0311% of the tradable shares (for every 100,000 tradable OncoCyte Corporation Common Stock shares, roughly 31 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against OncoCyte Corporation Common Stock.

Find out more about how you can short OncoCyte Corporation Common Stock stock.

OncoCyte Corporation Common Stock share dividends

We're not expecting OncoCyte Corporation Common Stock to pay a dividend over the next 12 months.

OncoCyte Corporation Common Stock share price volatility

Over the last 12 months, OncoCyte Corporation Common Stock's shares have ranged in value from as little as $1.15 up to $6.57. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OncoCyte Corporation Common Stock's is 1.9162. This would suggest that OncoCyte Corporation Common Stock's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

OncoCyte Corporation Common Stock overview

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides custom drug target discovery; assay design, development, and validation; and clinical trial and other testing services for pharmaceutical companies. OncoCyte Corporation was founded in 2009 and is headquartered in Irvine, California. .

Frequently asked questions

• What percentage of OncoCyte Corporation Common Stock is owned by insiders or institutions?

  Currently 10.463% of OncoCyte Corporation Common Stock shares are held by insiders and 48.643% by institutions.

• How many people work for OncoCyte Corporation Common Stock?

  Latest data suggests 51 work at OncoCyte Corporation Common Stock.

• When does the fiscal year end for OncoCyte Corporation Common Stock?

  OncoCyte Corporation Common Stock's fiscal year ends in December.

• Where is OncoCyte Corporation Common Stock based?

  OncoCyte Corporation Common Stock's address is: 15 Cushing, Irvine, CA, United States, 92618

• What is OncoCyte Corporation Common Stock's ISIN number?

  OncoCyte Corporation Common Stock's international securities identification number is: US68235C1071

• What is OncoCyte Corporation Common Stock's CUSIP number?

  OncoCyte Corporation Common Stock's Committee on Uniform Securities Identification Procedures number is: 68235C107